More than half of the drugs listed on the new TrumpRx website have a cheaper generic version on the market that can be ...

Generic drugmakers settle inflated prices claim by paying $18 million and adopting antitrust compliance reforms in a decade-long Connecticut lawsuit.

Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Washingtonians who purchased certain generic drugs between 2009 and 2019 could be eligible for compensation.

Generic drug suppliers weigh predictable and unpredictable factors that could impact the category in 2025. “This is the latest example of our actions to expand our portfolio in growing therapeutic ...

Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...

Pharmacists, other healthcare stakeholders say PBM reforms "level the playing field" ...